Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Cash from Operations (2019 - 2025)

AVITA Medical's Cash from Operations history spans 7 years, with the latest figure at 5438000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 32.71% year-over-year to 5438000.0; the TTM value through Dec 2025 reached 31195000.0, up 36.26%, while the annual FY2025 figure was 31195000.0, 36.26% up from the prior year.
  • Cash from Operations reached 5438000.0 in Q4 2025 per RCEL's latest filing, down from 5219000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 252000.0 in Q2 2022 to a low of 20864000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 8463777.78, with a median of 9023500.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: surged 102.01% in 2022, then plummeted 3711.51% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 572000.0 in 2021, then crashed by 500.7% to 3436000.0 in 2022, then tumbled by 216.15% to 10863000.0 in 2023, then rose by 25.61% to 8081000.0 in 2024, then soared by 32.71% to 5438000.0 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Cash from Operations are 5438000.0 (Q4 2025), 5219000.0 (Q3 2025), and 10229000.0 (Q2 2025).